Summary

The FDA has proposed removing oral phenylephrine, a common ingredient in over-the-counter cold medicines like NyQuil and Sudafed, due to evidence that it is ineffective as a nasal decongestant.

The proposal follows a unanimous vote by FDA advisers last year, and recent studies showing less than 1% of the drug is absorbed into the bloodstream when taken orally.

The public comment period ends on May 7, after which the FDA may finalize the ban.

  • iAmTheTot
    link
    fedilink
    arrow-up
    12
    ·
    6 hours ago

    Oh I’ll blame both, thank you very much. It’s well within certain governed agencies authority to say “you cannot sell that next to real medicine”.